{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T12:33:10Z","timestamp":1722169990737},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008359","name":"Maag Lever Darm Stichting","doi-asserted-by":"publisher","award":["TC 12-05"],"award-info":[{"award-number":["TC 12-05"]}],"id":[{"id":"10.13039\/501100008359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2020,6,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Faecal immunochemical testing (FIT) is suboptimal in detecting advanced neoplasia (AN). To increase the sensitivity and yield of a FIT-based screening programme, FIT could be combined with risk factors for AN. We evaluated the incremental yield of adding a family history questionnaire (FHQ) on colorectal cancer (CRC) and Lynch syndrome-associated tumours to the Dutch FIT-based screening programme.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Six thousand screen-naive individuals, aged 59\u201375 years, were invited to complete a FIT (FOB-Gold, cut-off 47\u2009\u00b5g Hb\/g faeces) and a validated online FHQ. Participants with a positive FIT and\/or positive FHQ, confirmed after genetic counselling, were referred for colonoscopy. Yield of detecting AN per 1000 invitees for the combined strategy was compared with the FIT-only strategy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the 5979 invitees, 1952 (32.6%) completed the FIT only, 2379 (39.8%) completed both the FIT and FHQ and 95 (1.6%) completed the FHQ only. Addition of the FHQ to FIT-based screening resulted in one extra case of AN detected after 16 additional colonoscopies, resulting in a yield of 19.6 (95% CI, 16.4\u201323.5) for the combined strategy versus 19.5 (95% CI, 16.3\u201323.3) for the FIT-only strategy (<jats:italic>p<\/jats:italic>\u2009=\u20091.0).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The addition of an FHQ to one round of FIT screening did not increase the detection of AN compared with FIT only (ClinicalTrials.gov NCT02698462).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41416-020-0832-8","type":"journal-article","created":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T23:06:08Z","timestamp":1587337568000},"page":"1865-1871","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Addition of an online, validated family history questionnaire to the Dutch FIT-based screening programme did not improve its diagnostic yield"],"prefix":"10.1038","volume":"122","author":[{"given":"Victorine H.","family":"Roos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank G. J.","family":"Kallenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manon","family":"van der Vlugt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelien J. C.","family":"Bongers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cora M.","family":"Aalfs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick M. M.","family":"Bossuyt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelien","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,20]]},"reference":[{"key":"832_CR1","unstructured":"Integraal Kankercentrum Nederland. Incidence of cancer of the colon, rectosigmoid, rectum. www.cijfersoverkanker.nl (2017)."},{"key":"832_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1056\/NEJM198809013190901","volume":"319","author":"B Vogelstein","year":"1988","unstructured":"Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M. et al. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 319, 525\u2013532 (1988).","journal-title":"N. Engl. J. Med."},{"key":"832_CR3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1056\/NEJMoa1100370","volume":"366","author":"AG Zauber","year":"2012","unstructured":"Zauber, A. G., Winawer, S. J., O\u2019Brien, M. J., Lansdorp-Vogelaar, I., van Ballegooijen, M., Hankey, B. F. et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N. Engl. J. Med. 366, 687\u2013696 (2012).","journal-title":"N. Engl. J. Med."},{"key":"832_CR4","unstructured":"Eramus MC\u2013NKI\/AvL. Landelijke Monitoring Bevolkingsonderzoek Darmkanker 2016. https:\/\/www.rivm.nl\/documenten\/landelijke-monitoring-bevolkingsonderzoek-darmkanker-2016 (2016)."},{"key":"832_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.7326\/M13-1484","volume":"160","author":"JK Lee","year":"2014","unstructured":"Lee, J. K., Liles, E. G., Bent, S., Levin, T. R. & Corley, D. A. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann. Intern. Med. 160, 171 (2014).","journal-title":"Ann. Intern. Med."},{"key":"832_CR6","doi-asserted-by":"publisher","first-page":"1217.e3","DOI":"10.1053\/j.gastro.2016.08.053","volume":"152","author":"DJ Robertson","year":"2017","unstructured":"Robertson, D. J., Lee, J. K., Boland, C. R., Dominitz, J. A., Giardiello, F. M., Johnson, D. A. et al. Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 152, 1217.e3\u20131237.e3 (2017).","journal-title":"Gastroenterology"},{"key":"832_CR7","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/apt.12446","volume":"38","author":"SC Ng","year":"2013","unstructured":"Ng, S. C., Ching, J. Y., Chan, V., Wong, M. C., Suen, B. Y., Hirai, H. W. et al. Diagnostic accuracy of faecal immunochemical test for screening individuals with a family history of colorectal cancer. Aliment. Pharmacol. Ther. 38, 835\u2013841 (2013).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"832_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1159\/000341738","volume":"86","author":"JM Cha","year":"2012","unstructured":"Cha, J. M., Lee, J. I., Joo, K. R., Shin, H. P., Park, J. J., Jeun, J. W. et al. First-degree relatives of colorectal cancer patients are likely to show advanced colorectal neoplasia despite a negative fecal immunochemical test. Digestion 86, 283\u2013287 (2012).","journal-title":"Digestion"},{"key":"832_CR9","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1053\/j.gastro.2010.01.054","volume":"138","author":"KW Jasperson","year":"2010","unstructured":"Jasperson, K. W., Tuohy, T. M., Neklason, D. W. & Burt, R. W. Hereditary and familial colon cancer. Gastroenterology 138, 2044\u20132058 (2010).","journal-title":"Gastroenterology"},{"key":"832_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/ajg.2014.435","volume":"110","author":"S Syngal","year":"2015","unstructured":"Syngal, S., Brand, R. E., Church, J. M., Giardiello, F. M., Hampel, H. L. & Burt, R. W. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am. J. Gastroenterol. 110, 223\u2013262 (2015).","journal-title":"Am. J. Gastroenterol."},{"key":"832_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1200\/JCO.2014.58.1322","volume":"33","author":"EM Stoffel","year":"2015","unstructured":"Stoffel, E. M., Mangu, P. B., Gruber, S. B., Hamilton, S. R., Kalady, M. F., Lau, M. W. et al. Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines. J. Clin. Oncol. 33, 209\u2013217 (2015).","journal-title":"J. Clin. Oncol."},{"key":"832_CR12","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0016-5085(00)70168-5","volume":"118","author":"HJ Jarvinen","year":"2000","unstructured":"Jarvinen, H. J., Aarnio, M., Mustonen, H., Aktan-Collan, K., Aaltonen, L. A., Peltomaki, P. et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118, 829\u2013834 (2000).","journal-title":"Gastroenterology"},{"key":"832_CR13","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1136\/bmj.38606.794560.EB","volume":"331","author":"I Dove-Edwin","year":"2005","unstructured":"Dove-Edwin, I., Sasieni, P., Adams, J. & Thomas, H. J. Prevention of colorectal cancer by colonoscopic surveillance in individuals with a family history of colorectal cancer: 16 year, prospective, follow-up study. BMJ 331, 1047 (2005).","journal-title":"BMJ"},{"key":"832_CR14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s10689-013-9658-3","volume":"12","author":"D Ait Ouakrim","year":"2013","unstructured":"Ait Ouakrim, D., Lockett, T., Boussioutas, A., Hopper, J. L. & Jenkins, M. A. Screening participation for people at increased risk of colorectal cancer due to family history: a systematic review and meta-analysis. Fam. Cancer 12, 459\u2013472 (2013).","journal-title":"Fam. Cancer"},{"key":"832_CR15","doi-asserted-by":"publisher","first-page":"e175","DOI":"10.1111\/codi.12117","volume":"15","author":"N Dekker","year":"2013","unstructured":"Dekker, N., Hermens, R. P., Nagengast, F. M., van Zelst-Stams, W. A. & Hoogerbrugge, N. Familial colorectal cancer risk assessment needs improvement for more effective cancer prevention in relatives. Colorectal Dis. 15, e175\u2013e185 (2013).","journal-title":"Colorectal Dis."},{"key":"832_CR16","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/j.1463-1318.2009.01898.x","volume":"11","author":"W Foo","year":"2009","unstructured":"Foo, W., Young, J. M., Solomon, M. J. & Wright, C. M. Family history? The forgotten question in high-risk colorectal cancer patients. Colorectal Dis. 11, 450\u2013455 (2009).","journal-title":"Colorectal Dis."},{"key":"832_CR17","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1097\/01.meg.0000231754.35340.fa","volume":"18","author":"DL Worthley","year":"2006","unstructured":"Worthley, D. L., Smith, A., Bampton, P. A., Cole, S. R. & Young, G. P. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer. Eur. J. Gastroenterol. Hepatol. 18, 1079\u20131083 (2006).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"832_CR18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/apt.13660","volume":"44","author":"FG Kallenberg","year":"2016","unstructured":"Kallenberg, F. G., Vleugels, J. L., de Wijkerslooth, T. R., Stegeman, I., Stoop, E. M., van Leerdam, M. E. et al. Adding family history to faecal immunochemical testing increases the detection of advanced neoplasia in a colorectal cancer screening programme. Aliment. Pharmacol. Ther. 44, 88\u201396 (2016).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"832_CR19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10689-015-9792-1","volume":"14","author":"FG Kallenberg","year":"2015","unstructured":"Kallenberg, F. G., IJ, J. E., Bossuyt, P. M., Aalfs, C. M. & Dekker, E. Validation of an online questionnaire for identifying people at risk of familial and hereditary colorectal cancer. Fam. Cancer 14, 401\u2013410 (2015).","journal-title":"Fam. Cancer"},{"key":"832_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gie.2018.09.011","volume":"89","author":"MES Bronzwaer","year":"2019","unstructured":"Bronzwaer, M. E. S., Depla, A., van Lelyveld, N., Spanier, B. W. M., Oosterhout, Y. H., van Leerdam, M. E. et al. Quality assurance of colonoscopy within the Dutch national colorectal cancer screening program. Gastrointest. Endosc. 89, 1\u201313 (2019).","journal-title":"Gastrointest. Endosc."},{"key":"832_CR21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1177\/2050640617700014","volume":"5","author":"MF Kaminski","year":"2017","unstructured":"Kaminski, M. F., Thomas-Gibson, S., Bugajski, M., Bretthauer, M., Rees, C. J., Dekker, E. et al. Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative. United Eur. Gastroenterol. J. 5, 309\u2013334 (2017).","journal-title":"United Eur. Gastroenterol. J."},{"key":"832_CR22","unstructured":"Hamilton, S. R. & Altonen, A. E. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System (IARC Press, Lyon, 2000)."},{"key":"832_CR23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1136\/gut.47.2.251","volume":"47","author":"RJ Schlemper","year":"2000","unstructured":"Schlemper, R. J., Riddell, R. H., Kato, Y., Borchard, F., Cooper, H. S., Dawsey, S. M. et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 47, 251\u2013255 (2000).","journal-title":"Gut"},{"key":"832_CR24","unstructured":"Dekker, E., van Leerdam, M., Hazewinkel, Y., Sanduleanu, S., Vasen, H. F., Lansdorp-Vogelaar, I. et al. Dutch Guideline for Colonoscopy Surveillance (Dutch Association of Gastroenterology Liver Physicians, Rotterdam, 2013)."},{"key":"832_CR25","doi-asserted-by":"crossref","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310, 2191\u20132194 (2013).","DOI":"10.1001\/jama.2013.281053"},{"key":"832_CR26","first-page":"1","volume":"18","author":"J Goyder","year":"2002","unstructured":"Goyder, J., Warriner, K. & Miller, S. Evaluating socio-economic status (SES) bias in survey nonresponse. J. Off. Stat. 18, 1\u201312 (2002).","journal-title":"J. Off. Stat."},{"key":"832_CR27","first-page":"367","volume":"64","author":"AE de Jong","year":"2006","unstructured":"de Jong, A. E. & Vasen, H. F. The frequency of a positive family history for colorectal cancer: a population-based study in the Netherlands. Neth. J. Med. 64, 367\u2013370 (2006).","journal-title":"Neth. J. Med."},{"key":"832_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1158\/1940-6207.CAPR-10-0345","volume":"4","author":"H Hampel","year":"2011","unstructured":"Hampel, H. & de la Chapelle, A. The search for unaffected individuals with Lynch syndrome: do the ends justify the means? Cancer Prev. Res. (Phila.) 4, 1\u20135 (2011).","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"832_CR29","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.ejca.2011.01.022","volume":"47","author":"N Dekker","year":"2011","unstructured":"Dekker, N., van Rossum, L. G., Van Vugt-van Pinxteren, M., van Stiphout, S. H., Hermens, R. P., van Zelst-Stams, W. A. et al. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening. Eur. J. Cancer 47, 1571\u20131577 (2011).","journal-title":"Eur. J. Cancer"},{"key":"832_CR30","doi-asserted-by":"publisher","first-page":"855","DOI":"10.4321\/S1130-01082009001200005","volume":"101","author":"M Navarro","year":"2009","unstructured":"Navarro, M., Binefa, G., Blanco, I., Guardiola, J., Rodriguez-Moranta, F. & Peris, M. Colorectal cancer screening: strategies to select populations with moderate risk for disease. Rev. Esp. Enferm. Dig. 101, 855\u2013860 (2009).","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"832_CR31","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.gie.2010.12.025","volume":"73","author":"F Armelao","year":"2011","unstructured":"Armelao, F., Paternolli, C., Franceschini, G., Franch, R., Orlandi, P. G., Miori, G. et al. Colonoscopic findings in first-degree relatives of patients with colorectal cancer: a population-based screening program. Gastrointest. Endosc. 73, 527\u201334.e2 (2011).","journal-title":"Gastrointest. Endosc."},{"key":"832_CR32","doi-asserted-by":"publisher","first-page":"e1002008","DOI":"10.1371\/journal.pmed.1002008","volume":"13","author":"E Quintero","year":"2016","unstructured":"Quintero, E., Carrillo, M., Leoz, M. L., Cubiella, J., Gargallo, C., Lanas, A. et al. Risk of advanced neoplasia in first-degree relatives with colorectal cancer: a large multicenter cross-sectional study. PLoS Med. 13, e1002008 (2016).","journal-title":"PLoS Med."},{"key":"832_CR33","unstructured":"Menko, F. H., Ter Stege, J. A., van der Kolk, L. E., Jeanson, K. N., Schats, W., Moha, D. A., et al. The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice. Fam. Cancer 18, 127\u2013135 (2019)."},{"key":"832_CR34","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1136\/jmg.37.10.810","volume":"37","author":"L Humphreys","year":"2000","unstructured":"Humphreys, L., Hunter, A. G., Zimak, A., O\u2019Brien, A., Korneluk, Y. & Cappelli, M. Why patients do not attend for their appointments at a genetics clinic. J. Med. Genet. 37, 810\u2013815 (2000).","journal-title":"J. Med. Genet."}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41416-020-0832-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-020-0832-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41416-020-0832-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:08:13Z","timestamp":1684616893000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-020-0832-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,20]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,6,9]]}},"alternative-id":["832"],"URL":"https:\/\/doi.org\/10.1038\/s41416-020-0832-8","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,20]]},"assertion":[{"value":"4 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for this study embedded in the national screening programme was obtained from the Dutch National Health Council (B21748-140305-PG).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was given by participants prior to filling out the validated online family history questionnaire.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors are willing to collaborate in further analyses, on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"E.D. has an endoscopic equipment on loan from FujiFilm and receives a research grant from FujiFilm. He has received a honorarium for consultancy from FujiFilm, Olympus, Tillots, GI Supply and CPP-FAP and a speakers\u2019 fee from Olympus, Roche and GI Supply. Also he is on the supervisory board of eNose. The other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was sponsored by The Dutch Digestive Foundation, who had no role in the study design, collection, analysis and interpretation of the data, writing the report or the submission of the paper.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding information"}}]}}